Roman Butler Fullerton & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,680
Closed -$208K – 259
2025
Q2
$208K Buy
+2,680
New +$187K 0.06% 236
2025
Q1
– Sell
-2,921
Closed -$260K – 230
2024
Q4
$260K Sell
2,921
-175
-6% -$14.9K 0.08% 198
2024
Q3
$281K Buy
3,096
+60
+2% +$5.04K 0.08% 205
2024
Q2
$240K Sell
3,036
-127
-4% -$10.4K 0.08% 207
2024
Q1
$267K Buy
3,163
+106
+3% +$8.82K 0.1% 180
2023
Q4
$226K Sell
3,057
-144
-4% -$10.1K 0.09% 191
2023
Q3
$215K Buy
+3,201
New +$233K 0.1% 176

Other funds holding GEHC

Roman Butler Fullerton & Co's GEHC Position: Q3 2025 in Review

Roman Butler Fullerton & Co sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 2,680 shares — an estimated $208K sold.

Roman Butler Fullerton & Co first reported a position in GEHC in Q3 2023 and held it in 7 quarters. The position peaked at $281K in Q3 2024. 1,281 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • Roman Butler Fullerton & Co reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 2,680 GE HealthCare shares in Q3 2025, an estimated $208K.
  • Roman Butler Fullerton & Co first reported a position in GE HealthCare in Q3 2023 and held it in 7 quarters.
  • Roman Butler Fullerton & Co's GE HealthCare position peaked at $281K in Q3 2024.
  • 1,281 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Roman Butler Fullerton & Co's 13F filing for Q3 2025, filed 6 Nov 2025.